Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


Biologics valuable treatment option for patients with inflammatory bowel disease

, the official journal of the American Gastroenterological Association (AGA) Institute. IBD includes Cro...

FDA Nanotechnology Task Force takes positive step forward

The Task Force is clear and candid in acknowledging the pervasive potential of nanotechnology to affect virtually every product category FDA regulates—from p...

A new century of Alzheimer's disease research

...

Support for Children's Health and Medicare Protection Act given to House leaders by ACP

Washington -- In a letter to leaders of the U.S. House of Representatives Ways and Means, and Energy and Commerce committees, the president of the American College of Physicians (ACP) today expressed support for the Children’s Health and Medicare Preotection (CHAMP) Act of 2007 (H.R. 3162). Representing 124,000 internal medicine physicians and medical student members, ACP is the largest medica...

White Blood Cell Booster May Help Cancer Patients Avoid Deadly Complications

DURHAM, N.C. -- Cancer patients who receive a drug that stimulates the growth of infection-fighting white blood cells may be significantly less likely to die from a chemotherapy-related complication characterized by fever and low white blood cell levels, according to a multi-institutional study led by researchers from the University of Rochester School of Medicine and Dentistry and the <A href...

Advanced therapy offers cure for relapsed cancer patient

About 90 percent of testicular cancer patients respond to traditional therapy, which involves multiple courses...

Researchers Discover How Cancer Evades the Immune System

A study on various kinds of cancer, conducted by researchers at the University of Southern California, has brought about the discovery of a new method to identify the genetic changes that enable tumours to evade the body's immune system. The findings, demonstrated in human breast and colorectal cancers, are significant to the field of medicine because they may lead to the advancem...

Structure of TB Enzyme Points the Way to New Drugs: Study

Swiss scientists said Monday that they have further evidence to suggest that an enzyme secreted by the microbe that causes tuberculosis would make a promising target for new drugs to combat the deadly infectious disease. The Swiss team first identified the enzyme, protein kinase G (PknG), as a promising drug target back in 2004. At the time, they said that the protein...

Singapore Dengue Cases Return to Epidemic Level

Dengue cases in affluent Singapore have reached 'epidemic' levels for the second time in the past month, health ministry data monitored Tuesday said. The Ministry of Health said 381 cases were reported between June 24 and 30, above the 'epidemic threshold' of 378 cases per week. Dengue cases crossed the threshold for the first time since 2005 earlier in June, when 401...

UN Calls for Pedal Power to Reduce Environmental Damage

More bicycle riding and other lifestyle changes are urgently needed to reduce climate-altering carbon emissions that are damaging Asia's health and could also threaten the economy, the World Health Organisation said Monday. Climate change contributes directly or indirectly to about 77,000 deaths per year in the region, according to WHO estimates. "So far the impact is...
[next]
(Date:4/17/2014)... Colo. (April 17, 2014) Two recent papers ... researcher and colleagues may help scientists develop treatments ... Yellow fever, Japanese encephalitis and other disease-causing flaviviruses. ... biochemistry and molecular genetics at the School of ... Howard Hughes Medical Institute, and colleagues recently published ...
(Date:4/17/2014)... personnel who served in Iraq and Afghanistan and ... (TBI) were compared to military personnel without TBI ... in measures of overall disability, cognitive function, post-traumatic ... reported in an article in Journal of ... Liebert, Inc., publishers. The article is available free ...
(Date:4/17/2014)... April 17, 2014-- Colic affects about one in five ... numerous pediatric visits during the first several months after ... symptoms was showing promise; however, the April 1, 2014 ... Sung, Valerie) reported on a study, "Probiotics and Infant ... L reuteri for infant colic did not ...
(Date:4/17/2014)... An international team led by researchers at UC ... which plays a key role in cell division, also ... is the first time the complex has been shown ... cyclin B1/Cdk1 an excellent target to control cellular energy ... research was published online today in the journal ...
(Date:4/17/2014)... a colored ribbon representing a disease. A pink ribbon is ... does one think of with lung cancer?, Although white has ... the disease, black may be the only one they think ... patients, primarily smokers between the ages of 51 to 79 ... felt by these patients, the emotional toll it can have ...
Breaking Medicine News(10 mins):Health News:CU researchers discover target for treating dengue fever 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2Health News:Dual role: Key cell division proteins also power up mitochondria 2Health News:Unraveling the 'black ribbon' around lung cancer 2
... eye’s retina is well on its way to offering ... as retinitis pigmentosa and age-related degeneration of the eye ... implant works for eye diseases in which healthy retinal ... eye’s photoreceptors.// These receptors convert images into electric impulses. Researchers ...
... Andhra Pradesh are to have a common e-platform which ... with the inauguration of www.aponline.gov.in, the state government's latest ... departments under one umbrella. The portal is being developed ... joint venture agreement.While TCS is enjoying 89% of the ...
... a common problem for heavy drinkers and the scientist have ... support the potentialities of a night out. ,Researchers at ... Clinic in Minnesota say the effect of alcohol on blood ... of healthy young adults, that blood vessels do not strengthen ...
... as the world's worst pandemic if the 40 million people ... drugs. The illness has killed 25 million people since the ... with HIV, which destroys the immune system. ,Without ... the death toll beyond the 40 million killed// by the ...
... babies suffer from asphyxia, which can lead to brain injury, ... per cent of babies who suffer from a moderate lack ... currently no effective treatments to reduce the risk of asphyxia ... lowering a baby's temperature may have beneficial effects. ,UK ...
... alpha gene are the cause of premature menopause which is ... of the total population. ,The University of Auckland team ... genetic test, which would allow women// with a family history ... They analysed DNA from women who had experienced POF, which ...
Cached Medicine News:
... order products are offered as 1-piece or ... The modular instruments may be customized with ... as ratchets, insulation and flush ports. Many ... Customer specifications may affect delivery times. ...
... Many special order products are offered ... extra long lengths. The modular instruments may ... other options such as ratchets, insulation and ... from Mediflex stock. Customer specifications may affect ...
... products are offered as 1-piece or modular, ... modular instruments may be customized with handles ... ratchets, insulation and flush ports. Many standard ... specifications may affect delivery times. , ...
... Many special order products are offered ... extra long lengths. The modular instruments may ... other options such as ratchets, insulation and ... from Mediflex stock. Customer specifications may affect ...
Medicine Products:
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... is available in its catalogue: ... Advanced Drug Delivery Systems -- Focus on ... STUDY OBJECTIVES A ...
(Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
(Date:1/14/2014)... HeartWare International, Inc . (NASDAQ: HTWR ... support technologies that are revolutionizing the treatment of advanced ... the fourth quarter of 2013 will be approximately $53 ... million. "Our full-year revenue growth of 87% ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4
... Omnicell, Inc . (NASDAQ: OMCL ... solutions and analytics software for healthcare facilities, today announced ... medication automation products for clinical use in China. ... Chinese hospitals to access advances in operational improvements similar ...
... N.J., Nov. 28, 2011  Johnson & Johnson (NYSE: JNJ ... Health Care Conference on Tuesday, Nov. 29 th at The ... Ethicon will present in a session scheduled at 8:00 a.m. (Eastern ... and other interested parties by accessing the Johnson & Johnson website ...
Cached Medicine Technology:Omnicell Introduces Groundbreaking Mandarin-Language Medication Automation System for Use in Chinese Clinical Settings 2Omnicell Introduces Groundbreaking Mandarin-Language Medication Automation System for Use in Chinese Clinical Settings 3Omnicell Introduces Groundbreaking Mandarin-Language Medication Automation System for Use in Chinese Clinical Settings 4Omnicell Introduces Groundbreaking Mandarin-Language Medication Automation System for Use in Chinese Clinical Settings 5